U.S. Metals and Mining Stock News

NYSE:ABX
NYSE:ABXInsurance

Abacus Global Management (ABX) Profitability Turn Reinforces Bullish Narrative Despite Valuation Tension

Abacus Global Management (ABX) has just wrapped up FY 2025 with fourth quarter revenue of US$71.9 million and basic EPS of US$0.07, rounding out a trailing twelve month EPS of US$0.38 on revenue of US$235.2 million. The company has seen quarterly revenue move from US$33.2 million and basic EPS of a loss of US$0.22 in Q4 2024 to US$71.9 million and EPS of US$0.07 in Q4 2025, while trailing twelve month net income shifted from a loss of US$24.0 million to a profit of US$36.5 million. This sets...
NYSE:AIN
NYSE:AINMachinery

Albany International’s 2026 World Engineering Day Role And Dividend Question

Albany International (NYSE:AIN) has been named an official partner for World Engineering Day for Sustainable Development 2026. The partnership spotlights the company’s role in materials science for sustainability and raises its profile with global engineering and policy audiences. For investors watching Albany International at a share price of $53.57, this new partnership adds a fresh layer of visibility that does not show up directly in recent price moves. The stock has seen a 26.3%...
NasdaqGS:BSY
NasdaqGS:BSYSoftware

Is It Time To Reassess Bentley Systems (BSY) After Recent Share Price Swings?

If you are wondering whether Bentley Systems is currently priced attractively or if the share price already reflects its quality, this article explains what the current valuation suggests. The stock last closed at US$38.19, with recent returns showing a 4.0% decline over 7 days, a 12.6% gain over 30 days, and results that are roughly flat year to date and lower over 1 and 3 years. Recent coverage has focused on how investors are reassessing software names as interest rates, infrastructure...
NYSE:DKS
NYSE:DKSSpecialty Retail

Has DICK'S Sporting Goods (DKS) Run Too Far After Its Strong Multi‑Year Share Price Gains

If you are wondering whether DICK'S Sporting Goods is reasonably priced or getting ahead of itself, this article will walk through how its current share price stacks up against several valuation checks. The stock last closed at US$192.16, with returns of 1.1% over the past year, 42.0% over 3 years and 175.9% over 5 years. Shorter term moves have been softer, with a 2.6% decline over 7 days, 6.0% decline over 30 days and 4.0% decline year to date. Recent attention on DICK'S Sporting Goods has...
NYSE:WRB
NYSE:WRBInsurance

Weighing W. R. Berkley (WRB) After Recent Share Price Weakness

If you are wondering whether W. R. Berkley is fairly priced or offering value right now, the starting point is to look closely at what the current share price actually reflects. The stock most recently closed at US$68.76, with returns of a 1.7% decline over 7 days, a 3.9% decline over 30 days, a 0.9% decline year to date, 11.7% over 1 year, 81.7% over 3 years and 135.1% over 5 years. This gives you a mix of short term weakness and longer term strength to weigh up. Recent news around W. R...
NasdaqGS:MRCY
NasdaqGS:MRCYAerospace & Defense

Mercury Systems Acquisition Brings Critical Manufacturing In House For Defense Programs

Mercury Systems (NasdaqGS:MRCY) has acquired SolderMask, Inc., adding specialized manufacturing capabilities and intellectual property. The deal brings in skilled personnel and assets that directly support more than 20 active Mercury programs tied to critical defense work. The acquisition is intended to accelerate production efficiency and strengthen delivery commitments across key customer contracts. Mercury Systems, trading at $78.16, has seen a 68.0% return over the past year and a 69.1%...
NYSE:PIPR
NYSE:PIPRCapital Markets

Assessing Piper Sandler (PIPR) After Recent Share Price Weakness And Capital Markets Activity

If you are wondering whether Piper Sandler Companies' current share price really reflects its underlying worth, or if the recent run leaves room for value, this article walks through that question step by step. The stock last closed at US$282.30, with returns showing a 3.8% decline over 7 days, a 17.4% decline over 30 days, a 19.3% decline year to date, a 14.2% gain over 1 year and a very large 3 year and 5 year return. Recent coverage around Piper Sandler Companies has focused on its role...
NYSE:U
NYSE:USoftware

Unity Insider Selling Raises Questions As Margins Improve And Growth Slows

Unity Software (NYSE:U) has seen significant insider selling activity while reporting expanding operating margins. At the same time, the company is working through revenue growth challenges that have drawn fresh attention from investors. The mix of insider sales, margin improvement, and pressure on growth is raising new questions about Unity's internal outlook and business direction. For investors watching Unity Software at a share price of $19.43, the recent pattern of insider selling...
NasdaqGM:LFMD
NasdaqGM:LFMDHealthcare Services

LifeMD (LFMD) Is Up 32.7% After Returning To Profitability And Expanding GLP‑1 Telehealth Offerings

In early March 2026, LifeMD, Inc. reported that it moved from a US$21.41 million annual net loss in 2024 to US$14.35 million net income in 2025, issued double‑digit revenue growth guidance for 2026, and highlighted expanding telehealth offerings including its oral Wegovy weight management launch with Novo Nordisk. This shift to profitability, combined with more than 322,000 active subscribers and growing GLP‑1 and women’s health programs, signals a business model that is scaling across...
NasdaqGS:NTAP
NasdaqGS:NTAPTech

Does The Recent Pullback Make NetApp (NTAP) Look Attractive On Valuation Grounds?

If you are wondering whether NetApp's share price really reflects what the business is worth today, you are not alone. That is exactly what this article will unpack. NetApp shares last closed at US$98.66, with returns of 9.5% over 1 year, 71.3% over 3 years and 58.3% over 5 years. However, the stock has seen a 2.4% decline over 7 days, 6.8% over 30 days and 7.3% year to date. Recent company specific headlines have continued to keep investor attention on NetApp, helping frame how the market...
NasdaqGS:MAPS
NasdaqGS:MAPSSoftware

WM Technology (MAPS) Margin Compression To 1.1% Tests Bullish Earnings Narratives

WM Technology (MAPS) closed out FY 2025 with Q4 revenue of about US$43.1 million and a basic EPS loss of roughly US$0.03, while trailing twelve month EPS stood at around US$0.02 on revenue of roughly US$174.7 million. Over recent periods the company has seen quarterly revenue range between about US$42.2 million and US$47.7 million, with EPS moving from a profit of roughly US$0.03 per share in late 2024 to small profits through most of 2025 before the latest quarterly loss. This has left...
NYSE:MC
NYSE:MCCapital Markets

Is It Time To Revisit Moelis (MC) After The Recent Share Price Slump

If you are wondering whether Moelis shares offer good value at today's price, it helps to step back and look at what the current market is implying about the business. The stock last closed at US$51.75, after a 7.8% decline over the past week, a 25.1% decline over the past month, and a 27.3% decline year to date, while still showing a 51.6% return over 3 years and 23.6% over 5 years. These recent moves have kept Moelis on investors' radars, with market commentary often linking advisory firms...
NasdaqCM:IMUX
NasdaqCM:IMUXBiotechs

Should Extended European Patent Protection for Vidofludimus Calcium Reshape Immunic’s (IMUX) Long-Term Value Proposition?

Immunic, Inc. recently secured a key European patent for its lead asset vidofludimus calcium, aligning protection with existing U.S. coverage and potentially extending exclusivity into the 2040s for chronic inflammatory and autoimmune indications. This expanded intellectual property protection materially underpins the company’s core therapeutic franchise by lengthening its runway to develop and, if approved, commercialize its main clinical asset. Against this backdrop, we’ll explore how the...
NasdaqCM:DTIL
NasdaqCM:DTILBiotechs

Precision BioSciences (DTIL) Q4 Profit Of US$19.2m Challenges Ongoing Loss Narrative

Precision BioSciences (DTIL) closed out FY 2025 with Q4 revenue of US$34.2 million and Basic EPS of US$1.01, alongside earnings from discontinued operations of US$0.9 million and net income excluding extra items of US$19.2 million. Over recent quarters, the company has seen revenue range from US$0.6 million in Q4 2024 to US$34.2 million in Q4 2025. Over the same period, quarterly Basic EPS has moved from a loss of US$2.22 in Q4 2024 to a profit of US$1.01 in Q4 2025. This sets up an earnings...
NYSE:TIC
NYSE:TICProfessional Services

TIC Solutions CEO Change And US$200m Buyback Reframe Turnaround Story

TIC Solutions (NYSE:TIC) has appointed Ben Heraud as its new CEO, succeeding long-serving leader Tal Pizzey. The company has also launched a $200 million share repurchase program. These changes were recently announced and have not been widely discussed in prior coverage. TIC Solutions is making these moves at a time when its share price is $7.25, with the stock showing a 40.3% decline over the past year and a 26.7% decline year to date. The new leadership and buyback plan arrive against...
NasdaqGS:EVCM
NasdaqGS:EVCMSoftware

EverCommerce (EVCM) Profitability Milestone Tests Bullish Narratives On Margin Sustainability

EverCommerce (EVCM) has wrapped up FY 2025 with fourth quarter revenue of US$151.2 million and basic EPS of US$0.03, alongside net income from ongoing operations of US$5.7 million. This caps a trailing twelve month period with revenue of US$588.9 million and EPS of US$0.10. Over recent quarters the company has seen revenue range from US$142.3 million to US$151.2 million, with quarterly EPS between US$0.01 and US$0.03. Over the same period, trailing twelve month net income from ongoing...
NYSE:FVRR
NYSE:FVRRProfessional Services

Is Fiverr (FVRR) Pricing Reflect Recent Share Slump Accurately

If you are wondering whether Fiverr International's current share price reflects its true worth, you are not alone. This article will walk you through what the numbers are actually saying about value. The stock has seen sizeable declines recently, with a 7.7% fall over the last week, a 27.6% decline over the last month, a 46.8% drop year to date, and a 59.2% decline over the past year. This extends a 68.5% and 95.3% fall across the last 3 and 5 years respectively. Recent attention on Fiverr...
NYSE:DCI
NYSE:DCIMachinery

Donaldson Acquisition Of Facet Shifts Focus Toward Critical Filtration Growth

Donaldson Company (NYSE:DCI) has agreed to acquire Facet, a provider of filtration solutions for aerospace, defense, and power generation. The deal is intended to expand Donaldson's product lineup and deepen its presence in durable end markets tied to critical infrastructure and equipment. The acquisition adds exposure to customers that require highly technical filtration in mission critical applications. Donaldson Company focuses on filtration technologies across industrial, engine, and...
OTCPK:BUKS
OTCPK:BUKSAerospace & Defense

Butler National (OTCPK:BUKS) Margin Expansion Reinforces Bullish Earnings Narratives In Q3 2026

Butler National (BUKS) has reported Q3 2026 revenue of US$26.9 million and basic EPS of US$0.10, set against trailing twelve month revenue of US$91.9 million and EPS of US$0.30 that came with 44.1% earnings growth and a 21.4% net margin over the past year. The company has seen quarterly revenue move from US$21.2 million in Q3 2025 to US$26.9 million in Q3 2026 and basic EPS from US$0.05 to US$0.10 across the same periods, with trailing net income reaching US$19.7 million, which positions the...
NasdaqGS:TNYA
NasdaqGS:TNYABiotechs

How TN-301 Progress And Alnylam Deal At Tenaya Therapeutics (TNYA) Has Changed Its Investment Story

In early March 2026, Tenaya Therapeutics reported a narrower full-year 2025 net loss of US$90.6 million and highlighted new preclinical data for TN-301 in Duchenne muscular dystrophy alongside a research collaboration with Alnylam Pharmaceuticals on up to 15 cardiovascular gene targets that could yield as much as US$1.13 billion in milestones. Together, these updates underscore how Tenaya is pairing emerging HDAC6 science in DMD and heart failure with a genetically guided partnership model...
NasdaqGS:CAPR
NasdaqGS:CAPRBiotechs

Capricor Therapeutics (CAPR) Posts US$50 Million H1 Loss Reinforcing Bearish Cash Burn Narrative

Capricor Therapeutics (CAPR) has just posted its FY 2025 first half results with total revenue of US$0 million and a basic EPS loss of US$1.10, while trailing twelve month revenue sits at US$13.39 million with a basic EPS loss of US$1.66. Over recent periods, the company has reported revenue of US$8.88 million and US$13.39 million across the two halves of FY 2024, alongside basic EPS losses of US$0.66 and US$0.51. This provides context for how current margins remain under pressure. With...
NYSE:CSTM
NYSE:CSTMMetals and Mining

Constellium Buyback Targets Dilution While Shares Trade Below Valuation Estimates

Constellium (NYSE:CSTM) has announced a new share repurchase program of up to $300 million, authorized through the end of 2028. The new program replaces the previous buyback authorization. Constellium intends to use some repurchased shares to settle employee equity obligations, aiming to limit future dilution for shareholders. Constellium, trading at $24.61, has laid out a fresh $300 million buyback plan that directly addresses dilution, which many shareholders watch closely. The stock has...
NasdaqGM:OBIO
NasdaqGM:OBIOMedical Equipment

Orchestra BioMed (OBIO) First Profitable Quarter Tests Bearish Unprofitability Narrative

Orchestra BioMed Holdings (OBIO) just posted a sharp step up in activity for FY 2025, with fourth quarter revenue at US$30.9 million and basic EPS of US$0.10, compared with a full year where trailing twelve month revenue sat at US$33.5 million and EPS on that basis was a loss of US$1.11. The company has seen revenue move from quarterly levels below US$1 million through most of the year to the current US$30.9 million print, while quarterly basic EPS shifted from losses between US$0.49 and...
NasdaqGS:OLED
NasdaqGS:OLEDSemiconductor

Has Universal Display (OLED) Share Slide Created A Valuation Opportunity In OLED Materials?

If you have been wondering whether Universal Display's current share price reflects its true worth, you are not alone. This article aims to unpack that question clearly. The stock last closed at US$94.07, and returns of a 3.1% decline over 7 days, a 28.8% decline over 30 days, and a 22.8% decline year to date, as well as a 36.6% decline over 1 year, a 31.9% decline over 3 years, and a 57.2% decline over 5 years, may have reset expectations and risk perceptions for many investors. Recent news...